• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 5
  3. Author

Online ISSN: 2515-8260

Volume9, Issue5

CLINICAL STUDY OF EPIDURAL METHYLPREDNISOLONE INJECTION IN TREATMENT OF PROLAPSED INTER-VERTEBRAL DISC (PIVD) CASES

    Dr. Vinit Gupta

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 5, Pages 589-594

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: A vast majority of prolapsed inter-vertebral disc (PIVD) occur at L4-L5 and L5-S1 level causing L5 and S1 radiculopathy. Lumbar epidural steroid injection (LESI) forms an important part of modern spine care, in cases not responding to conservative management for more than 3 months. Present study was aimed to study epidural methylprednisolone injection in treatment of prolapsed inter-vertebral disc (PIVD) cases.
Material and Methods: Present study was hospital based, prospective, observational study, conducted patients aged 18 to 65 years suffering from mechanical LBP with radiation due to PIVD at L4-L5 and L5-S1 (diagnosed with MRI) with symptom duration of less than 1year, symptom severity of ≥6 cm VAS score for pain, and not responding to conservative management for 3 months, received epidural steroid injection of methylprednisolone (80 mg).
Results: In present study, out of 55 enrolled patients, 42 completed follow-up. Majority were females (54.76 %), left side affected (52.38 %), Housewife (42.86 %) & labourers (26.19 %). Mean age was 38.32 ± 9.18 years, mean BMI was 27.89 ± 4.12 kg/m2, average duration of pain was 13.33± 4.16 weeks. L4-L5 (61.9 %) were commonly involved as compared to L5-S1 (38.1 %). As per MRI Grading, Grade 2 (66.67 %) were more than Grade 3 (33.33 %) cases. We noted a significant improvement in Oswestry Disability Index Score (ODI) and the Visual Analogue Scale (VAS) as compared to baseline & at 6-month follow-up values, difference was highly significant (< 0.001).
Conclusion: Epidural use of methyl prednisone is safe and efficacious treatment modality in management of low back pain and radicular pain due to a prolapsed lumbar intervertebral disc.
Keywords:
    Epidural methyl prednisone radicular pain prolapsed lumbar intervertebral disc
  • PDF (366 K)
  • XML
(2022). CLINICAL STUDY OF EPIDURAL METHYLPREDNISOLONE INJECTION IN TREATMENT OF PROLAPSED INTER-VERTEBRAL DISC (PIVD) CASES. European Journal of Molecular & Clinical Medicine, 9(5), 589-594.
Dr. Vinit Gupta. "CLINICAL STUDY OF EPIDURAL METHYLPREDNISOLONE INJECTION IN TREATMENT OF PROLAPSED INTER-VERTEBRAL DISC (PIVD) CASES". European Journal of Molecular & Clinical Medicine, 9, 5, 2022, 589-594.
(2022). 'CLINICAL STUDY OF EPIDURAL METHYLPREDNISOLONE INJECTION IN TREATMENT OF PROLAPSED INTER-VERTEBRAL DISC (PIVD) CASES', European Journal of Molecular & Clinical Medicine, 9(5), pp. 589-594.
CLINICAL STUDY OF EPIDURAL METHYLPREDNISOLONE INJECTION IN TREATMENT OF PROLAPSED INTER-VERTEBRAL DISC (PIVD) CASES. European Journal of Molecular & Clinical Medicine, 2022; 9(5): 589-594.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 29
  • PDF Download: 39
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus